Samantha is a corporate attorney who focuses her practice on private mergers and acquisitions. She represents private equity firms, venture capital funds, and emerging companies on all aspects of private financial and strategic mergers and acquisitions. Samantha negotiates and structures platform and follow-on acquisitions, leveraged recapitalizations, divestments, joint ventures, and strategic alliances, among other arrangements.

Samantha’s counseling work includes advising portfolio companies and other clients on structuring, corporate governance, reorganizations, and other matters. Her experience covers a diverse range of industry sectors, such as technology, software, health care, life sciences, and automotive. Samantha’s clients include both U.S. and foreign investors and corporations, and she handles both inbound and outbound investments.

• Represented a U.S.-based private equity fund in numerous platform and add-on investments in a wide range of industries, including software, outsourcing, and IT infrastructure transactions.
• Represented a purchaser in a Section 363 sale of pharmaceutical company’s assets.
• Advised Hikma Pharmaceuticals in its $425 million acquisition of Custopharm, a provider of generic sterile injectable products, from Water Street Healthcare Partners.
• Advised Pyramid Laboratories, a drug product contract development and manufacturing organization (CDMO), on its sale to Audax and the associated seller rollover investment.
• Advised Core Avionics & Industrial Inc., a leading provider of development tools, software libraries, and deployable software packages that enable safety-critical GPU-based computing, including certified graphics rendering, autonomy, and AI applications, in its acquisition by Lynx Software Technologies, Inc.
• Represented a private equity firm in its acquisition of a branded aftermarket accessories business used to outfit and rig kayaks.
• Represented a private equity firm in the sale of an approved FHA lender and Ginnie Mae multifamily issuer, a Freddie Mac seller/servicer and a commercial mortgage servicer, and the subsequent sale to a publicly held financial institution.
• Represented a private equity firm in numerous add-on acquisitions in the car wash business.
• Represented a Missouri-based pre-clinical laboratory in its sale to a private equity-backed CRO platform.
• Represented a private equity fund successfully selling a platform enterprise through an auction-based sale process, with retention of representation and warranty insurance.
• Represented a private equity fund in its acquisition of multiple software companies having numerous foreign operating subsidiaries.